Clinical Pharmacokinetics of Mefloquine

[1]  J. Karbwang,et al.  Pharmacokinetics of prophylactic mefloquine in Thai healthy volunteers. , 1991, The Southeast Asian journal of tropical medicine and public health.

[2]  N. White,et al.  Fatal Plasmodium falciparum malaria after an inadequate response to quinine treatment. , 1990, The Journal of infectious diseases.

[3]  C. C. Campbell,et al.  Neurologic reactions after a therapeutic dose of mefloquine. , 1989, The New England journal of medicine.

[4]  J. Bauchet,et al.  Divided-dose kinetics of mefloquine in man. , 1989, British journal of clinical pharmacology.

[5]  W. Wernsdorfer,et al.  Single dose kinetic study of the triple combination mefloquine/sulphadoxine/pyrimethamine (Fansimef) in healthy male volunteers. , 1989, British journal of clinical pharmacology.

[6]  J. Karbwang,et al.  Determination of mefloquine in biological fluids using high performance liquid chromatography. , 1989, The Southeast Asian journal of tropical medicine and public health.

[7]  N. White,et al.  Studies of mefloquine bioavailability and kinetics using a stable isotope technique: a comparison of Thai patients with falciparum malaria and healthy Caucasian volunteers. , 1987, British journal of clinical pharmacology.

[8]  M. Molyneux,et al.  Plasma and whole blood mefloquine concentrations during treatment of chloroquine-resistant falciparum malaria with the combination mefloquine-sulphadoxine-pyrimethamine. , 1987, British journal of clinical pharmacology.

[9]  N. White COMBINATION TREATMENT FOR FALCIPARUM PROPHYLAXIS , 1987, The Lancet.

[10]  O. V. Stetten,et al.  High-performance liquid chromatographic analysis of mefloquine and its main metabolite by direct plasma injection with pre-column enrichment and column , 1986 .

[11]  A. Breckenridge,et al.  The pharmacokinetics of mefloquine in man: lack of effect of mefloquine on antipyrine metabolism. , 1985, British journal of clinical pharmacology.

[12]  N. White,et al.  Intragastric mefloquine is absorbed rapidly in patients with cerebral malaria. , 1985, The American journal of tropical medicine and hygiene.

[13]  K. Silamut,et al.  Binding of quinine to plasma proteins in falciparum malaria. , 1985, The American journal of tropical medicine and hygiene.

[14]  N. White Clinical Pharmacokinetics of Antimalarial Drugs , 1985, Clinical pharmacokinetics.

[15]  T. Harinasuta,et al.  TRIALS OF MEFLOQUINE IN VIVAX AND OF MEFLOQUINE PLUS 'FANSIDAR' IN FALCIPARUM MALARIA , 1985, The Lancet.

[16]  R. Nagel,et al.  On the mechanism for the red-cell accumulation of mefloquine, an antimalarial drug. , 1984, Biochimica et biophysica acta.

[17]  Guoqiao Li,et al.  ANTIMALARIAL ACTIVITY OF MEFLOQUINE AND QINGHAOSU , 1982, The Lancet.

[18]  D. E. Schwartz,et al.  Highly sensitive and specific determination of mefloquine in biological fluids using gas chromatography mass spectrometry with selected ion monitoring. , 1981, Biomedical mass spectrometry.

[19]  J.D.R. Thomas Recent developments in chromatography and electrophoresis , 1981 .

[20]  D. E. Schwartz,et al.  Kinetic studies of mefloquine and of one of its metabolites, Ro 21-5104, in the dog and in man. , 1980, Acta tropica.

[21]  K. Barry,et al.  Kinetics of a new antimalarial, mefloquine , 1979, Clinical pharmacology and therapeutics.

[22]  J. Haslam,et al.  GLC determination of whole blood antimalarial concentrations. , 1979, Journal of pharmaceutical sciences.

[23]  C. D. Fitch,et al.  Chloroquine Resistance in Malaria: Accessibility of Drug Receptors to Mefloquine , 1979, Antimicrobial Agents and Chemotherapy.

[24]  N. Molek,et al.  The absorption, distribution, and excretion in mice of the antimalarial mefloquine, erythro-2,8-bis(trifluoromethyl)-alpha-(2-piperidyl)-4-quinolinemethanol hydrochloride. , 1978, Drug metabolism and disposition: the biological fate of chemicals.

[25]  J. M. Grindel,et al.  Quantitation of the antimalarial agent, mefloquine, in blood, plasma, and urine using high-pressure liquid chromatography. , 1977, Journal of pharmaceutical sciences.

[26]  P. Dayton,et al.  Studies of the disposition and metabolism of mefloquine HCl (WR 142,490), a quinolinemethanol antimalarial, in the rat. Limited studies with an analog, WR 30,090. , 1975, Drug metabolism and disposition: the biological fate of chemicals.

[27]  N. White,et al.  Absorption kinetics of mefloquine in pregnant patients with chloroquine-resistant falciparum malaria , 1990 .

[28]  F. Churchill,et al.  Determination of mefloquine by electron-capture gas chromatography after phosgene derivatization in biological samples and in capillary blood collected on filter paper. , 1988, Journal of chromatography.

[29]  A. Breckenridge,et al.  Effect of oral contraceptive steroids on the clinical course of malaria infection and on the pharmacokinetics of mefloquine in Thai women. , 1988, Bulletin of the World Health Organization.

[30]  U. Hellgren,et al.  High-performance liquid chromatographic assay for the simultaneous monitoring of mefloquine and its acid metabolite in biological samples using protein precipitation and ion-pair extraction. , 1988, Journal of chromatography.

[31]  P. Heizmann,et al.  Single-dose kinetics of mefloquine in Brazilian male subjects. , 1987, Bulletin of the World Health Organization.

[32]  W. Wernsdorfer,et al.  A phase-III clinical trial of mefloquine in children with chloroquine-resistant falciparum malaria in Thailand. , 1987, Bulletin of the World Health Organization.

[33]  J. Karbwang Clinical pharmacology of mefloquine. , 1987 .

[34]  W. Wernsdorfer,et al.  Mefloquine, sulfadoxine, and pyrimethamine in the treatment of symptomatic falciparum malaria: a double-blind trial for determining the most effective dose. , 1987, Bulletin of the World Health Organization.

[35]  U. Dubach,et al.  Single-dose investigation of possible interactions between the components of the antimalarial combination Fansimef. , 1987, Chemotherapy.

[36]  D. E. Schwartz,et al.  Urinary excretion of mefloquine and some of its metabolites in African volunteers at steady state. , 1987, Chemotherapy.

[37]  R. Lambe,et al.  Gas chromatographic determination of mefloquine in human and dog plasma using electron-capture detection. , 1985, Journal of chromatography.

[38]  U. Sheth,et al.  An open, randomized, phase III clinical trial of mefloquine and of quinine plus sulfadoxine-pyrimethamine in the treatment of symptomatic falciparum malaria in Brazil. , 1985, Bulletin of the World Health Organization.

[39]  P. Heizmann,et al.  Determination of the antimalarial mefloquine in human plasma by gas chromatography with electron-capture detection. , 1984, Journal of Chromatography A.

[40]  J. M. Kofi Ekue,et al.  A double-blind comparative clinical trial of mefloquine and chloroquine in symptomatic falciparum malaria. , 1983, Bulletin of the World Health Organization.

[41]  J. M. Souza A phase II clinical trial of mefloquine in Brazilian male subjects. , 1983 .

[42]  D. E. Schwartz,et al.  Multiple-dose kinetic study of mefloquine in healthy male volunteers. , 1983, Chemotherapy.

[43]  I. Kapetanovic,et al.  Analysis of the antimalarial, mefloquine, in blood and plasma using high-performance liquid chromatography. , 1983, Journal of chromatography.

[44]  D. Hartmann,et al.  Single Dose Kinetics of Mefloquine in Man , 1982 .

[45]  R. Lasserre,et al.  Single-dose treatment of falciparum malaria with mefloquine: field studies with different doses in semi-immune adults and children in Burma. , 1982, Bulletin of the World Health Organization.

[46]  E. Griesser,et al.  [Metabolism of Ro 21-5998 (mefloquine) in the rat (author's transl)]. , 1980, Arzneimittel-Forschung.

[47]  A. Frigerio,et al.  Quantitative determination of the antimalarial drug mefloquine and of its main metabolite in plasma by direct densitometric measurement on thin-layer chromatographic plates. , 1980 .

[48]  P. Phintuyothin,et al.  Single-dose therapy of falciparum malaria with mefloquine or pyrimethamine-sulfadoxine. , 1979, Bulletin of the World Health Organization.